share_log

HC Wainwright & Co. Maintains Buy on Purple Biotech, Raises Price Target to $9

HC Wainwright & Co. Maintains Buy on Purple Biotech, Raises Price Target to $9

HC Wainwright & Co.维持对 Purple Biotech的买入,将目标价上调至9美元
Benzinga ·  2023/08/31 04:18

HC Wainwright & Co. analyst Emily Bodnar maintains Purple Biotech (NASDAQ:PPBT) with a Buy and raises the price target from $7 to $9.

HC Wainwright&Co.分析师艾米丽·博德纳维持紫色生物科技公司(纳斯达克股票代码:PPBT)的买入,并将目标价从7美元上调至9美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发